Market cap
₹25,500 cr
Loading the extract…
Loading the extract…
Healthcare · Pharmaceuticals
RUBICON · NSE RUBICON · BSE 544578
Market cap
₹25,500 cr
Price
1,542
52w high
1,590
52w low
571
PE
136
Industry PE
—
Book value
82
Dividend yield
0.1%
ROCE
21
ROE
18.6
Debt / equity
—
EPS
—
No description in this extract.
| Line | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Depreciation | 45 | 37 | 39 | 36 | 34 |
| Dividend Payout % | 10 | 0 | 0 | -2 | 0 |
| EPS in Rs | 14.95 | 8.72 | 5.98 | -33.31 | -132.39 |
| Expenses | 1,354 | 1,028 | 699 | 375 | 353 |
| Interest | 42 | 37 | 31 | 19 | 10 |
| Net Profit | 247 | 134 |
| Line | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|
| Depreciation | 12 | 12 | 12 | 10 | 10 | 9 | 8 |
| EPS in Rs | 4.65 | 4.42 | 3.49 | 2.81 | 2.35 | 2.5 | 2.27 |
| Expenses | 395 | 367 | 318 | 273 | 286 | 244 | 234 |
| Interest | 10 | 10 | 11 | 11 | 12 |
| Line | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|
| DIIs | 9.43 | 10.02 | 9.45 |
| FIIs | 7.52 | 7.54 | 7.99 |
| Promoters | 59.76 | 59.86 | 59.99 |
| Public | 23.29 | 22.57 | 22.57 |
| 91 |
| -17 |
| -67 |
| OPM % | 23 | 20 | 18 | 4.7 | -12 |
| Operating Profit | 400 | 256 | 155 | 18 | -39 |
| Other Income | 8 | 12 | 18 | 25 | 17 |
| Profit before tax | 321 | 195 | 103 | -11 | -66 |
| Sales | 1,754 | 1,284 | 854 | 394 | 314 |
| Tax % | 23 | 31 | 12 | 53 | 2 |
| 8 |
| 7 |
| Net Profit | 77 | 73 | 54 | 43 | 36 | 38 | 34 |
| OPM % | 23 | 23 | 23 | 22 | 20 | 22 | 21 |
| Operating Profit | 119 | 108 | 94 | 79 | 72 | 70 | 62 |
| Other Income | 3 | 4 | 1 | 1 | 0 | 0 | 3 |
| Profit before tax | 99 | 91 | 72 | 60 | 51 | 53 | 49 |
| Raw PDF | — | — | — | — | — | — | — |
| Sales | 514 | 476 | 412 | 352 | 358 | 313 | 296 |
| Tax % | 22 | 20 | 25 | 27 | 29 | 28 | 30 |